Senate joins House to pass sweeping new health bill
The U.S. Senate voted overwhelmingly on Wednesday to support sweeping legislation that will reshape the way the Food and Drug Administration approves new medicines.
Cytori Therapeutics Inc said it has suspended enrollments in two trials of its experimental cell therapy for heart failure patients after a safety review.
The company's shares fell 13 percent in extended trade.
Cerebrovascular events - those related to blood vessels in the brain - were reported in studies to evaluate safety and feasibility of adipose-derived regenerative cells in patients with ischemic heart disease, the company said.
Symptoms occurred in three patients, the company said. Two patients' symptoms fully resolved within a short period, it said, while the third has experienced a substantial resolution.
Cytori's shares closed at $2.10 on the Nasdaq on Tuesday.
(Reporting by Shailesh Kuber; Editing by Ted Kerr)
STOCKHOLM The Swedish government on Thursday launched a campaign to become the new host of the London-based European drugs agency after Britain's vote to leave the European Union and compete with offers from other EU members including Spain, France and Poland.
CLEVELAND Ohio lawmakers approved a bill that bans abortion once a fetal heartbeat can be detected, as early as six weeks after conception, clearing the way for one of the most stringent abortion restrictions in the United States if it becomes law.